(COVID-19) Ikhithi yovavanyo lwe-IgM/IgG ye-Antibody Rapid (Latex Chromatography)
Ukusetyenziswa okucetywayo
Yenzelwe ukufunyaniswa okukhawulezileyo, okusemgangathweni kwe-acute acute breathing syndrome 2 (SARS-CoV-2) IgG/IgM ye-antibody kwigazi lomntu lonke, i-serum okanye isampuli yeplasma.Uvavanyo kufuneka lusetyenziswe njengoncedo ekuxilongeni isifo sosulelo lwe-coronavirus, esibangelwa yi-SARS-CoV-2.Uvavanyo lubonelela ngeziphumo zovavanyo lokuqala.Iziphumo ezibi aziluthinteli usulelo lwe-SARS-CoV-2 kwaye azinakusetyenziswa njengesiseko sonyango okanye esinye isigqibo solawulo.Ukusetyenziswa kwe-in vitro diagnostic kuphela.
Umgaqo woVavanyo
Isekwe kumgaqo wokubamba i-immunoassay yokumisela izilwa-buhlungu ze-COVID-19 ze-IgG/IgM kwigazi lomntu lonke, i-serum kunye neplasma.Xa isampulu yongezwa kwisixhobo sovavanyo, isampulu iya kufunxwa kwisixhobo ngesenzo se-capillary, ixutywa ne-SARS-CoV-2 recombinant antigen-color latex conjugate kwaye iqukuqela kwi-membrane eqatywe ngaphambili.
Imixholo ephambili
Amacandelo anikiweyo adweliswe kwitheyibhile.
| Icandelo REF REF | B001C-01 | B001C-25 |
| Ikhasethi yoVavanyo | 1 uvavanyo | Iimvavanyo ezingama-25 |
| Iyalahlwa | Iqhekeza eli-1 | 25 iipcs |
| Isampulu yeLysis Solution | ityhubhu e-1 | 25 iityhubhu |
| Imiyalelo yokusetyenziswa | Iqhekeza eli-1 | Iqhekeza eli-1 |
| Isatifikethi sokuThobela | Iqhekeza eli-1 | Iqhekeza eli-1 |
Operation Flow
Ukuba i-reagent igcinwe efrijini kwi-4-8 ℃, susa ikhadi le-reagent kwaye uilibrate kwiqondo lokushisa elingaphezulu kwemizuzu engama-30.
1. Vula ibhegi yefoyile ye-aluminium yekhadi lokuhlola.Susa ikhadi lovavanyo kwaye ulibeke ngokuthe tye etafileni.
2. Sebenzisa i-pipette kwi-aspirate isampuli (i-serum, i-plasma okanye igazi elipheleleyo) kwaye udibanise i-10μL kumngxuma wesampulu yekhadi lovavanyo, uze udibanise isisombululo se-dilution ye-60μL ngokukhawuleza.Qala ukubala.
3. Imizuzu eyi-15 kamva, funda iziphumo ngokubonakalayo.(Qaphela: SUKUFUNDA iziphumo emva kwemizuzu engama-20!)
Isiphumo sokutolika
1.Isiphumo esibi
Ukuba kuphela umgca wolawulo lomgangatho C ubonakala kwaye imigca yokubona i-G kunye ne-M ayibonisi, oko kuthetha ukuba akukho noveli ye-antibody ye-coronavirus efunyenweyo kwaye isiphumo sibi.
2. Isiphumo Esilungileyo
2.1 Ukuba zombini umgca wolawulo lomgangatho C kunye nomgca wokubona u-M uyavela, oko kuthetha ukuba kubhaqwe i-antibody ye-IgM ye-novel coronavirus, kwaye isiphumo sibe sithi positive kwi-antibody ye-IgM.
2.2 Ukuba zombini umgca wolawulo lomgangatho C kunye nomgca wokubona u-G uyavela, oko kuthetha ukuba kubhaqwe i-antibody ye-IgG yenoveli kwaye isiphumo sithi si-positive kwi-antibody ye-IgG.
2.3 Ukuba zombini umgca wolawulo lomgangatho C kunye nemigca yokubona i-G kunye ne-M ibonakala, oko kuthetha ukuba i-novel coronavirus IgG kunye ne-IgM antibodies zifunyenwe, kwaye umphumo ulungile kuzo zombini ii-antibodies ze-IgG kunye ne-IgM.
3. Isiphumo esingasebenziyo
Ukuba umgca wokulawula umgangatho we-C awukwazi ukubonwa, iziphumo ziya kuba zingasebenzi kungakhathaliseki ukuba umgca wokuvavanya ubonisa, kwaye uvavanyo kufuneka luphindwe.
Ulwazi lweodolo
| Igama lemveliso | Ikati.Hayi | Ubungakanani | Umzekelo | Beka ubomi kwishelufa | Trans.& Sto.Temp. |
| (COVID-19) Ikhithi yovavanyo lwe-IgM/IgG ye-Antibody Rapid (Latex Chromatography) | B001C-01 | Uvavanyo olu-1/ikhithi | ISerum/Plasma/Igazi Elipheleleyo | Iinyanga ezili-18 | 2-30℃ / 36-86℉ |
| B001C-01 | Iimvavanyo ezingama-25/ikhithi |
